Fact CheckerSign in

NCT07871227Not yet recruiting

Follow-up After Oncological Resection by Endoscopic Colorectal ESD (Endoscopic Submucosal Dissection)

Follow-up After Oncological Resection by Endoscopic Colorectal ESD

Source: ClinicalTrials.gov · Last updated 16 Oct 2026

Brief summary (registry, in English)

Colorectal cancer is a common and leading cause of death. Pre-cancerous lesions, as well as some so-called superficial cancers, can be resected via endoscopy. The technique chosen in the case of extensive lesions or superficial cancer is submucosal dissection. This technique helps avoid surgery, which has a higher morbidity and mortality (especially due to the non-preservation of the organ).

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
1200 (estimated)
First submitted
6 Oct 2026
Start date
Oct 2026
Primary completion date
Dec 2030
Lead sponsor
University Hospital, Bordeaux
NCT number
NCT07871227

What you commit to

  • Study type: Observational
  • Planned participants: 1200
  • From Oct 2026 to the primary completion date, Dec 2030
  • 14 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of Crohn's disease (ICD-10: K50) or ulcerative colitis (ICD-10: K51).
  • History of familial adenomatous polyposis and/or genetic predisposition to colorectal cancer (ICD-10: D12.6+0/1/2/4/5 and 6).
  • Malignant tumor of the colon staged ≥ T2.

Other

  • Patients not included in the FECCo registry.
  • Documented objection through the non-opposition form following review of the information notice

Who the study is looking for

  • Adult patient (18 years or older).
  • Presumed diagnosis of localized superficial colorectal cancer (T1) during endoscopy using the Conecct classification, confirmed by subsequent histopathological analysis.
  • Patient included in the French Colorectal ESD Cohort in Experts Centers (FECCo registry) since September 2019 for submucosal dissection.
  • Histological analysis of the resection specimen revealing a superficial colorectal adenocarcinoma with high risk of lymphatic recurrence, defined by at least one of the following criteria: submucosal invasion depth ≥ 1000 microns, tumor budding grade ≥ 2, presence of lymphatic and/or vascular emboli.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (14)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Clinique de l'Anjou
Coordinator of this site? Confirm its status
AngersFranceUnknown status
Chu Dijon Bourgogne
Coordinator of this site? Confirm its status
DijonFranceUnknown status
CHU de Limoges
Coordinator of this site? Confirm its status
LimogesFranceUnknown status
Clinique Jean Mermoz
Coordinator of this site? Confirm its status
LyonFranceUnknown status
Hospices Civils de Lyon - Hôpital Édouard Herriot
Coordinator of this site? Confirm its status
LyonFranceUnknown status
Clinique Jules Verne
Coordinator of this site? Confirm its status
NantesFranceUnknown status
CHU Nîmes
Coordinator of this site? Confirm its status
NîmesFranceUnknown status
AP-HP Hôpital Cochin
Coordinator of this site? Confirm its status
ParisFranceUnknown status
AP-HP Hopital Europeen Georges Pompidou
Coordinator of this site? Confirm its status
ParisFranceUnknown status
Paris - Saint Joseph
Coordinator of this site? Confirm its status
ParisFranceUnknown status
CHU de Bordeaux
Coordinator of this site? Confirm its status
PessacFranceUnknown status
CHU de Rennes
Coordinator of this site? Confirm its status
RennesFranceUnknown status
Clinique Santé Atlantique
Coordinator of this site? Confirm its status
Saint-HerblainFranceUnknown status
CHRU de Nancy
Coordinator of this site? Confirm its status
Vandœuvre-lès-NancyFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.